The Avis Territorial Center for Pharmaceutical Information
(CTIAP for its acronym in French), concluded that none of the four vaccines
being implemented in France are safe or effective, given that all received
authorization for emergency use with insufficient clinical evidence, for which
requires their immediate suspension.
The CTIAP, which is linked to the Cholet public hospital in
western France, recently published a report showing that the vaccines used
against CCP viruses not only underwent insufficient clinical testing, but the
quality of the active substances, their "excipients , some of which are
new ”, and the manufacturing processes are poor.
The research team is led by Dr. Catherine Frade, renowned
pharmacist, who worked on public data reported by the European Medicines Agency
(EMA), regarding injections from Pfizer, Moderna, AstraZeneca and Janssen
(Johnson & Johnson) .
The first wake-up call published in the report is that all
these products only have temporary marketing authorizations. In addition, all
are subject to further studies that go as far as 2024, which will make it
almost impossible to complete them considering the accelerated way in which
vaccines are being distributed.
In this sense, the CTIAP, warns that all vaccines began to
be marketed and actively applied in humans before the "quality test of the
active substance and the finished product" took place.

Post a Comment
We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...